Arkolith/Insider Trading/VNDA/Form 4

Polymeropoulos Mihael Hristos

President and CEO, DirectorVanda Pharmaceuticals Inc. (VNDA) · full profile →Form 4 · filed Mar 5, 2025
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2025Buy(P)5K$5.01$25K2.3M
Mar 5, 2025Buy(P)5K$5.03$25K2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-033845) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML